Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Immunology|January 29, 2014
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsisPengfei Li, Grant Bledsoe, Zhi-Rong Yang, et al.
Human Gene Therapy|May 24, 2006
Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene deliveryGrant Bledsoe, Bo Shen, Yuyu Yao, et al.
Biological Chemistry|February 26, 2010
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healingJulie Chao, Bo Shen, Lin Gao, et al.
Experimental Cell Research|July 10, 2015
Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expressionYouming Guo, Pengfei Li, Grant Bledsoe, et al.
Plos One|May 26, 2017
Plasma kallistatin in critically ill patients with severe sepsis and septic shockWei-Chieh Lin, Chang-Wen Chen, Lee Chao, et al.
Human Gene Therapy|November 4, 2006
Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammationJulie Chao, Hang Yin, Yu-Yu Yao, et al.
Diabetes|April 28, 2005
Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic ratsDavid Montanari, Hang Yin, Eric Dobrzynski, et al.
American Journal of Physiology. Renal Physiology|October 3, 2008
Intermedin ameliorates vascular and renal injury by inhibition of oxidative stressMakoto Hagiwara, Grant Bledsoe, Zhi-Rong Yang, et al.
Hypertension (Dallas, Tex. : 1979)|September 5, 2008
Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formationJulie Chao, Hang Yin, Lin Gao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 24, 2010
Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signalingBo Shen, Lin Gao, Yi-Te Hsu, et al.
Pageof 11